THE ROLE OF CILIAL PROTEIN#1 IN DIABETIC KIDNEY DISEASE (DKD)

S REDZEPAGIC1, C HUANG1, C POLLOCK1, U PANCHAPAKESAN1
1Renal Research Group, Kolling Institute, Royal North Shore Hospital, University of Sydney, Sydney, Australia

Aim: To assess if primary cilial Protein#1 is regulated by transforming growth factor beta (TGFB1) and evaluate if gene-silencing with sequence-specific LNA GapmeRs (Exiqon) affect downstream markers of kidney fibrosis.
Background: Primary cilia on kidney proximal tubule cells (PTCs) are sensitive to luminal mechanosensory stimuli and are a novel pathway linking luminal changes with tubular dysfunction. Our target, primary cilia Protein#1, is integral to the hedgehog signalling pathway, hence relevant to kidney fibrosis.
Methods: Primary cultures of mice PTC and human kidney (HK2) cells were transfected using control and Protein#1-sequence-specific LNA GapmeRs. Mice PTCs and HK2 cells were exposed to 5 or 2 ng/ml TGFB1 respectively for 48h. Kidney tissue from control and mice with streptozotocin-induced diabetes mellitus was harvested. mRNA expression of Protein#1 and downstream profibrotic markers were assessed.
Results: Protein#1 was upregulated in kidneys of diabetic mice (N=10-12,P<0.001) and HK2 cells (N=4,P<0.05) exposed to TGFB1 for 48h. A similar trend was seen in mice PTCs exposed to TGFB (N=4,P=0.08).Mice PTCs exposed to TGFB upregulated fibronectin (N=4,P<0.05) and collagen1 (N=3,P<0.05). Silencing of Protein#1 using sequence-specific LNA GapmeRs reduced expression of collagen1 (N=3,P<0.05), with a similar trend observed for fibronectin (N=4,P<0.06).HK2 cells exposed to TGFB upregulated collagen 4 (N=4,P<0.05), plasminogen activator inhibitor (PAI) (N=4,P=0.01) with a similar  trend observed for fibronectin (N=4,P=0.08). Silencing of Protein#1-as above reduced fibronectin (N=4,P<0.01) and  PAI (N=4,P<0.001). A similar trend was observed for collagen 4 expression (N=4,P=0.06).
Conclusion: Primary cilia Protein#1 is upregulated in mice diabetic kidneys and in TGFB1-exposed HK2 cells. Gene-silencing with Protein#1-sequence-specific LNA GapmeR reduced downstream markers of kidney fibrosis, suggesting its involvement in kidney fibrosis thus suggesting Protein#1 is a potential therapeutic target.


Biography:
Sanela Redzepagic is a nephrologist from Sydney. She is undertaking a PhD candidature at The University of Sydney, with Prof. Pollock’s Renal Research Lab, Koling Institute – Royal North Shore Hospital, to investigate a role of LNCRNA in the DKD

About ANZSN

The ASM is hosted by Australian and New Zealand Society of Nephrology.

The aims of the Society are to promote and support the study of the kidney and urinary tract in health and disease, and to ensure the highest professional standards for the practice of nephrology in Australia and New Zealand.

Conference Managers

Please contact the team at Conference Design with any questions regarding the Annual Scientific Meeting

© 2015 - 2016 Conference Design Pty Ltd